![Johnson & Johnson Launches the First and Only Daily Disposable Multifocal Toric Contact Lens[1] for Astigmatic Adults living with Presbyopia](https://moneycompass.com.my/wp-content/uploads/2026/02/1298d71d_502d_4bb1_9019_512d4a14e9a7_Logo-RvV18m.jpeg){kind=logo}
The brand also expands daily disposable options for astigmatic adults with the launch of ACUVUE® OASYS MAX 1-Day for ASTIGMATISM, bringing pioneering innovation that delivers visual clarity and comfort [+],[**],[2],[3] as vision needs evolve.
SINGAPORE, Feb. 10, 2026 /PRNewswire/ — Today, Johnson & Johnson announced the launch of two new contact lenses in Singapore – ACUVUE® OASYS MAX 1-Day MULTIFOCAL for ASTIGMATISM – the first and only daily disposable multifocal toric contact lens for people with both astigmatism and presbyopia,[1] and ACUVUE® OASYS MAX 1-Day for ASTIGMATISM. Designed to address the evolving needs of astigmatic patients, both lenses provide exceptional comfort, clarity and stability,[+],[**],[2],[3] plus crisp, clear vision at all distances and in all lighting conditions for presbyopes.[***],[3]
Astigmatism affects about 50% of the population,[4] making it one of the most common vision conditions. It is characterized by imperfections in the curvature of the eye, leading to distorted or blurred vision and visual fatigue. Presbyopia, commonly beginning in the early to mid-40s, is the gradual loss of near vision and it is estimated that up to 2.1 billion people globally will develop presbyopia by 2030 due to our ageing population.[5]
Vision changes are often shaped by more than one factor. In Singapore, studies suggest that close to 60% of adults experience astigmatism alongside presbyopia or other refractive changes,[6] highlighting the varying vision needs that may happen concurrently. These overlapping vision changes affect the quality of how we experience the demands of everyday life – from long workdays, parenting routines to night driving and social activities.
Traditionally, there has been a gap for people with astigmatism when they begin to experience presbyopia. They may have had to make compromises by either switching from daily contact lenses to reusables or layering reading glasses over their contact lenses.
“Astigmatism can cause visual discomfort and eye strain, which is particularly inconvenient for patients at night as they experience light glares, streaks or halos from head- or street-lights. Uncorrected astigmatism makes it tiring to focus for long periods of time, especially in the digital age we’re in. We see an unmet need in both astigmatism and presbyopia as vision needs continue to evolve alongside the way people live, work and interact with the world,” said Ashish Kohli, Vice President, Asia Pacific, Vision Care, Johnson & Johnson.
“With the launch of these two new toric contact lenses for astigmatism in Singapore, we are expanding the ACUVUE® OASYS MAX 1-Day portfolio and are pleased to offer eye care professionals the first and only complete family of daily disposable contact lenses,[###],[1] helping them meet patients’ changing vision needs. This new offering underscores our commitment to delivering tailored solutions that provide all day comfort, clarity and stability for people struggling with astigmatism.[+],[**],[2],[3]
Regular eye examinations are essential to accurately diagnose vision conditions, enabling eye care professionals to recommend the right solutions while ensuring patients are properly fitted with contact lenses that best support their vision needs.
To learn more about the two new ACUVUE® OASYS MAX 1-Day toric contact lenses or to search for an eye care professional, visit https://www.acuvue.com/en-sg/oasys-max/
ACUVUE® OASYS MAX 1-Day MULTIFOCAL for Astigmatism
The ACUVUE® OASYS MAX 1-Day MULTIFOCAL for Astigmatism contact lens is built with the combination of four powerful proprietary technologies[7] which enable its comfort and visual results: EYELID STABILIZED Design helps the lens stay put, so vision is not distorted or blurry when you blink or move your head.[3],[7] PUPIL OPTIMIZED Design helps meet presbyopic vision needs, even as you age and your vision continues to change.[2] TearStable Technology helps keep the lens hydrated, facilitating end of day comfort.[††] [9],[10],[11] Finally, the OptiBlue Light Filter has the highest level of blue-violet light filter, with 60% blue-violet light filtering.[^[‡‡] [7],[3] It has also shown proven performance across its key claims:
- 95% of patients report clear vision during daily activities[§],[***],[3]
- 87% of patients report clear vision while driving at night[§],[***],[3]
- 92% of patients report comfort throughout the entire day[¶],[***],[3]
ACUVUE® OASYS MAX 1-Day for Astigmatism
Featuring a combination of three powerful proprietary technologies[4] – EYELID STABILIZED Design, TearStable Technology, and OptiBlue Light Filter – this contact lens delivers exceptional comfort, clarity and stability[+],[**],[2],[3] and has shown proven performance across its key claims:
- 96% of patients report stable vision[%],
- Nearly 99% of patients report clear and reliable vision[+],[3]
- 89% of patients report all-day comfort[%],[3]
Next-Generation Innovation Tailored for the Astigmatic Eye
Both contact lenses have been developed with a patient-centric design,[*],[7],[12] enabling eye care professionals to provide more tailored solutions for astigmatic patients.
ACUVUE® OASYS MAX 1-Day lenses will now be available in spherical, toric, multifocal, and multifocal toric designs, providing coverage for 96.2% of patients’ eyes.[###],[8] To learn more about the two new ACUVUE® OASYS MAX 1-Day toric contact lenses or to search for an eye care professional, visit https://www.acuvue.com/en-sg/oasys-max/
[†]About Vision at Johnson & Johnson
Johnson & Johnson has a deep legacy in developing transformational new products that improve the health of patients’ eyes. We have a bold ambition: Vision Made Possible – improving sight for more than 40 million people each year. Through cutting-edge innovation, expertise in material and optical science, and advanced technologies, we are revolutionizing the way people see and experience the world.
Visit us at jjvision.com, follow @JNJVision on X, Johnson & Johnson Vision on LinkedIn, and @JNJVision on Facebook.
About Johnson & Johnson
At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity. Learn more about our MedTech sector’s global scale and deep expertise in cardiovascular, orthopaedics, surgery and vision solutions at https://thenext.jnjmedtech.com. Follow us at @JNJMedTech and on LinkedIn.
Johnson & Johnson Vision Care, Inc., a Johnson & Johnson Company.
Important information for contact lens wearers: ACUVUE Contact Lenses are available by prescription only for vision correction. An eye care professional will determine whether contact lenses are right for you. Although rare, serious eye problems can develop while wearing contact lenses. To help avoid these problems, follow the wear and replacement schedule and the lens care instructions provided by your eye doctor. Do not wear contact lenses if you have an eye infection, or experience eye discomfort, excessive tearing, vision changes, redness or other eye problems. If one of these conditions occurs, remove the lens and contact your eye doctor immediately. For more information on proper wear, care and safety, talk to your eye care professional, call 1-800-843-2020, or download the Patient Instruction Guides.
Cautions Concerning Forward-Looking Statements
This press release contains “forward-looking statements” as defined in the Private Securities Litigation Reform Act of 1995 related to ACUVUE OASYS MAX 1-Day MULTIFOCAL for ASTIGMATISM and ACUVUE OASYS MAX 1-Day for ASTIGMATISM contact lenses. The reader is cautioned not to rely on these forward-looking statements. These statements are based on current expectations of future events. If underlying assumptions prove inaccurate or known or unknown risks or uncertainties materialize, actual results could vary materially from the expectations and projections of Johnson & Johnson. Risks and uncertainties include, but are not limited to: competition, including technological advances, new products and patents attained by competitors; uncertainty of commercial success for new products; the ability of the company to successfully execute strategic plans; impact of business combinations and divestitures; challenges to patents; changes in behavior and spending patterns or financial distress of purchasers of health care products and services; and global health care reforms and trends toward health care cost containment. A further list and descriptions of these risks, uncertainties and other factors can be found in Johnson & Johnson’s most recent Annual Report on Form 10-K, including in the sections captioned “Cautionary Note Regarding Forward-Looking Statements” and “Item 1A. Risk Factors,” and in Johnson & Johnson’s subsequent Quarterly Reports on Form 10-Q and other filings with the Securities and Exchange Commission. Copies of these filings are available online at www.sec.gov, www.jnj.com, www.investor.jnj.com or on request from Johnson & Johnson. Johnson & Johnson does not undertake to update any forward-looking statement as a result of new information or future events or developments.
|
[+] T2B descriptive summaries: n≥144 |
|
[*] Versus publicly available information for contact lenses for astigmatism as of July 2023 |
|
[**] T2B descriptive summaries: n = 171 |
|
[***] n=171 |
|
[###] Full/complete family consists of sphere, multifocal, toric and multifocal toric contact lenses |
|
[§] Model-adjusted percent estimate |
|
[¶] T3B descriptive summaries: n=171 |
|
[%] T3B descriptive summaries: n ≥ 144 |
|
[^] Filtering of HEV light by contact lenses has not been demonstrated to confer any health benefit to the user, including but not limited to retinal protection, protection from cataract progression, reduced eye strain, improved contrast, improved acuity, reduced glare, improved low light vision, or improved circadian rhythm/sleep cycle. The Eye Care Professional should be consulted for more information. |
|
[††]Versus ACUVUE® OASYS 1-Day, Dailies Total1®, My Day®, Infuse™ and Precision 1®. |
|
[‡‡]Versus publicly available information for standard daily use contact lenses as of December 2023. |
© Johnson & Johnson and its affiliates 2026
2026PP05096
|
[1] JJV Data on File 2025, World’s First and Only Daily Disposable Multifocal Toric Contact Lens |
|
[2] JJV Data on file, 2025. Subjective Comparative and Descriptive Standalone Claims for ACUVUE® OASYS MAX 1-Day Contact Lenses for ASTIGMATISM |
|
[3] JJV Data on file, 2024: Subjective Standalone Claims for ACUVUE® OASYS MAX 1-Day MULTIFOCAL Contact Lenses for ASTIGMATISM |
|
[4] Young G, Sulley A & Hunt C. Prevalence of Astigmatism in Relation to Soft Contact Lens Fitting; Eye & CL, 2011: 37: 20-25 |
|
[5] Markoulli M, et al. BCLA CLEAR Presbyopia: Epidemiology and impact. Cont Lens Anterior Eye. 2024 Aug;47(4):102157. |
|
[7] JJV Data on File: Technical Description of ACUVUE® OASYS MAX 1-Day MULTIFOCAL for ASTIGMATISM |
|
[8]JJV Data on file. 2024. SKU Coverage Claims for ACUVUE® OASYS MAX 1-Day and ACUVUE® OASYS MAX 1-Day MULTIFOCAL Brand Contact Lenses. |
|
[9] JJV Data on File 2022. Effect on Tear Film and Evaluation of Visual Artifacts with ACUVUE® OASYS MAX 1-Day Family. |
|
[10] JJV Data on File 2022. JJV Data on File 2022 TearStable™ Technology Definition. |
|
[11] JJV Data on File 2022. Material Properties: 1-DAY ACUVUE® MOIST, 1-DAY ACUVUE® TruEye®, ACUVUE® OASYS 1-Day with HydraLuxe® Technology and ACUVUE® OASYS MAX 1-Day with TearStable™ Technology Brand Contact Lenses and other daily disposable contact lens brands. |
|
[12] JJV Data on file 2022. CSM- ACUVUE® PUPIL OPTIMIZED DESIGN Technology: JJVC contact lenses, design features, and associated benefits. |
View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/johnson–johnson-launches-the-first-and-only-daily-disposable-multifocal-toric-contact-lens1-for-astigmatic-adults-living-with-presbyopia-302682496.html
SOURCE Johnson & Johnson
